复星医药于江苏成立药业公司

Group 1 - The establishment of Jiangsu Fosun Jinnuo Pharmaceutical Co., Ltd. has been recently reported, with a registered capital of 30 million yuan [1] - The legal representative of the new company is Peng Shaoping, indicating a structured leadership [1] - The business scope includes drug production, entrusted drug production, drug wholesale, drug import and export, chemical product sales (excluding licensed chemical products), and medical research and experimental development [1] Group 2 - The company is jointly held by Jiangsu Wanbang Biopharmaceutical Group Co., Ltd. and Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., indicating strong backing from established entities in the pharmaceutical sector [1]